A Multivariate Analysis of Predictors of Papillary Thyroid Carcinoma in Thyroid Nodules：Significance of Thyroglobulin ;Antibody
林玉晶,肖文华,洪天配,高洪伟,李智飞,梅放,陶立元
DOI: https://doi.org/10.3969/j.issn.1009-6604.2017.02.008
2017-01-01
Abstract:Objective To investigate the association of thyroid autoantibodies with papillary thyroid carcinoma ( PTC ) in patients with thyroid nodules . Methods We retrospectively analyzed clinical and pathological data in 2128 patients with thyroid nodules who underwent thyroidectomy at our hospital from January 2012 to December 2014.Among the 2128 patients enrolled, 807 (37.9%) patients were diagnosed as PTC and 1321 ( 62.1%) patients were classified into benign nodules .Logistic regression analysis was used to assess whether risk of PTC was associated with other clinical and pathological data , including age , sex, pathologically defined chronic lymphocytic thyroiditis (CLT), thyroglobulin antibody (TGAb), thyroid peroxidase antibody (TPOAb), and thyroid stimulating hormone (TSH, thyrotropin). Results As cpmpared with patients with benign nodules , those with PTC had a younger age [M=43 (Q1 =33, Q3 =53) years old vs.51 (39, 59) years old, P=0.000], higher rate of coexisting CLT [27.1%(219/807) vs.12.7%(168/1321), P=0.000], higher rate of positive TGAb [26.6%(215/807) vs.13.7%(181/1321), P=0.000] and positive TPOAb [26.0% (210/807) vs.18.8% (249/1321), P =0.000] and higher level of serum TSH [1.67 (1.11, 2.37) mIU/L vs.1.42 (0.91, 2.12) mIU/L, P=0.000].Logistic analysis showed that coexistence of CLT (OR=1.843, 95%CI:1.375-2.471, P=0.001) and positivity of TGAb (60-99 U/ml: OR=2.005, 95%CI:1.237-3.249, P=0.005;≥500 U/ml:OR=2.146, 95%CI:1.281-3.594, P=0.004), but not positivity of TPOAb, were independently correlated with risk of PTC.Moreover, higher level of serum TSH was associated with an increased risk of PTC . Conclusion In patients with thyroid nodules, coexistence of pathologically defined CLT , positivity of TGAb, and elevation of TSH level are associated with increased risk of PTC .